COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Verseau Therapeutics develops macrophage checkpoint modulators to reprogram tumor-associated macrophages, leveraging siRNA lipid‑nanoparticle delivery and an all‑human translational platform to discover and validate multi‑modal targets including PSGL-1.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
